The potential therapeutic regimen for overcoming resistance to osimertinib due to rare mutations in NSCLC
暂无分享,去创建一个
Yong He | Yubo Wang | Caiyu Lin | Chong Zhang | Cong-hua Lu | Jun Kang | Chen Hu | Yimin Zhang | R. Han
暂无分享,去创建一个
Yong He | Yubo Wang | Caiyu Lin | Chong Zhang | Cong-hua Lu | Jun Kang | Chen Hu | Yimin Zhang | R. Han